| Health / Medical Topics |
MAGE-A1, Her-2/neu, FBP Peptides Cancer Vaccine
A synthetic cancer vaccine comprised of multiple peptides derived from MAGE-1A, Her-2/neu, and folate binding protein (FBP), with potential immunostimulating and antineoplastic properties. MAGE-A1, Her-2/neu, and FBP proteins are simultaneously over-expressed in various cancer cell types, such as epithelial ovarian cancer. The MAGE-A1, Her-2/neu, FBP peptides cancer vaccine includes the peptides MAGE-A1:161-169, FBP:191-199, Her-2/neu:369-377, MAGE-A1:96-104, and Her-2/neu:754-762. Vaccination with this cancer vaccine may activate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing the corresponding antigens, resulting in tumor cell lysis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A synthetic peptide cancer vaccine consisting of human leukocyte antigen HLA-A1-restricted peptide derived from human melanoma antigen 3 (MAGE-3) with potential immunostimulating…
A cancer vaccine consisting of a peptide derived from MAGE-3 and the pan-DR epitope (PADRE), an immunostimulant. Vaccination with CY-2010 may…
A peptide derived from MAGE-3, a tumor-associated protein expressed by a variety of cancer cell types, including melanoma, breast, colon, lung, and…
A protein found in many types of tumors but not in most normal tissues. Vaccines using pieces of the MAGE-3 protein are…
A synthetic peptide consisting of the amino acids 170 through 178 of the MAGE-12 melanoma antigen. MAGE-12 170-178 has been identified…
A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an…
